https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01892
Phase 2 Study of Glesatinib, Sitravatinib or Mocetinostat in Combination With Nivolumab in...
Phase 2 Study of Glesatinib, Sitravatinib or Mocetinostat in Combination With Nivolumab in Non-Small Cell Lung Cancer